Novavax CEO John Jacobs said in a statement that the approval was a "significant milestone" that solidifies a path for people to access the vaccine. The company missed out on the pandemic vaccine ...

In 2025 four alarming outbreaks—measles tick fevers COVID-19 resurgence and mosquito-borne diseases—could be early warnings of the next global threat Disease X ...